Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of LKB1 (STK11) and Its Prognostic and Therapeutic Implications in Non-Small Cell Lung Cancer: A Retrospective Cohort Study

NCT07710599 is registered in ClinicalTrials.gov with Ling Zhiqiang as lead sponsor.

NCT NCT07710599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07710599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of LKB1 (STK11) and Its Prognostic and Therapeutic Implications in Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Lead sponsor
Ling Zhiqiang
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2024
Completion date
October 1, 2027
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer